EUPRAXIA PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$268.27 thousand for the 12-month period ending 2024-12-31, per its 40-F filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2025-03-20
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2024-12-31 | -$268.27K 40-F · filed 2025-03-20 |
| 2023-12-31 | $242.46K 40-F · filed 2025-03-20 |
| 2022-12-31 | $11.57K 40-F · filed 2024-04-01 |